BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

178 related articles for article (PubMed ID: 15228494)

  • 1. Prospects for new tuberculosis treatment in Africa.
    Mwinga A; Bernard Fourie P
    Trop Med Int Health; 2004 Jul; 9(7):827-32. PubMed ID: 15228494
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Development of antituberculous drugs: current status and future prospects].
    Tomioka H; Namba K
    Kekkaku; 2006 Dec; 81(12):753-74. PubMed ID: 17240921
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Frontier of mycobacterium research--host vs. mycobacterium].
    Okada M; Shirakawa T
    Kekkaku; 2005 Sep; 80(9):613-29. PubMed ID: 16245793
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Managing TB in the 21st century: existing and novel drug therapies.
    Guy ES; Mallampalli A
    Ther Adv Respir Dis; 2008 Dec; 2(6):401-8. PubMed ID: 19124385
    [TBL] [Abstract][Full Text] [Related]  

  • 5. HIV infection and multidrug-resistant tuberculosis: the perfect storm.
    Wells CD; Cegielski JP; Nelson LJ; Laserson KF; Holtz TH; Finlay A; Castro KG; Weyer K
    J Infect Dis; 2007 Aug; 196 Suppl 1():S86-107. PubMed ID: 17624830
    [TBL] [Abstract][Full Text] [Related]  

  • 6. New drugs and new regimens for the treatment of tuberculosis: review of the drug development pipeline and implications for national programmes.
    Lienhardt C; Vernon A; Raviglione MC
    Curr Opin Pulm Med; 2010 May; 16(3):186-93. PubMed ID: 20216421
    [TBL] [Abstract][Full Text] [Related]  

  • 7. New approaches to the treatment of latent tuberculosis.
    Sterling TR
    Semin Respir Crit Care Med; 2008 Oct; 29(5):532-41. PubMed ID: 18810686
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Reform of Japan's NTP and its technical perspectives].
    Mori T
    Kekkaku; 2004 Oct; 79(10):587-604. PubMed ID: 15631111
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Rising standards for tuberculosis drug development.
    Balganesh TS; Alzari PM; Cole ST
    Trends Pharmacol Sci; 2008 Nov; 29(11):576-81. PubMed ID: 18799223
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Present-day treatment of tuberculosis and latent tuberculosis infection.
    Pérez-Camacho I; Rivero-Juárez A; Kindelán JM; Rivero A
    Enferm Infecc Microbiol Clin; 2011 Mar; 29 Suppl 1():41-6. PubMed ID: 21420566
    [TBL] [Abstract][Full Text] [Related]  

  • 11. New tuberculosis therapeutics: a growing pipeline.
    Spigelman MK
    J Infect Dis; 2007 Aug; 196 Suppl 1():S28-34. PubMed ID: 17624823
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Study on the efficacy and safety of short-term treatment including fluoroquinolones anti-tuberculosis drugs for rifampicin resistant pulmonary tuberculosis].
    Kang WL; Xie YG; Tan WG; Chu NH; Li L; You YH; Yang YZ; Wang XM; Yan XL; Miao ZP; Duanmu HJ
    Zhonghua Liu Xing Bing Xue Za Zhi; 2009 Feb; 30(2):179-83. PubMed ID: 19565883
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Which agents should we use for the treatment of multidrug-resistant Mycobacterium tuberculosis?
    Di Perri G; Bonora S
    J Antimicrob Chemother; 2004 Sep; 54(3):593-602. PubMed ID: 15282233
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Current treatment of tuberculosis].
    García Ramos R; Lado Lado FL; Túnez Bastida V; Pérez del Molino Bernal ML; Cabarcos Ortiz de Barrón A
    An Med Interna; 2003 Feb; 20(2):91-100. PubMed ID: 12703164
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Tuberculosis drug development: progress, challenges, and the road ahead.
    Ginsberg AM
    Tuberculosis (Edinb); 2010 May; 90(3):162-7. PubMed ID: 20382086
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Emerging drugs for active tuberculosis.
    Ginsberg AM
    Semin Respir Crit Care Med; 2008 Oct; 29(5):552-9. PubMed ID: 18810688
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The role of surgery and fluoroquinolones in the treatment of multidrug-resistant tuberculosis.
    Törün T; Tahaoğlu K; Ozmen I; Sevim T; Ataç G; Kir A; Güngör G; Bölükbaşi Y; Maden E
    Int J Tuberc Lung Dis; 2007 Sep; 11(9):979-85. PubMed ID: 17705975
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Peptide deformylase--a promising therapeutic target for tuberculosis and antibacterial drug discovery.
    Sharma A; Khuller GK; Sharma S
    Expert Opin Ther Targets; 2009 Jul; 13(7):753-65. PubMed ID: 19530983
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Overcoming the global crisis: "yes, we can", but also for TB ... ?
    Ottenhoff TH
    Eur J Immunol; 2009 Aug; 39(8):2014-20. PubMed ID: 19672895
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Fighting tuberculosis: an old disease with new challenges.
    Tripathi RP; Tewari N; Dwivedi N; Tiwari VK
    Med Res Rev; 2005 Jan; 25(1):93-131. PubMed ID: 15389729
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.